Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Pain 14Neoplasms 6Colonic Neoplasms 5Agnosia 5Lung Neoplasms 4Head and Neck Neoplasms 4Cancer Pain 4Breast Neoplasms 4Rectal Neoplasms 3Prostatic Neoplasms 3Pain, Postoperative 3Urinary Bladder Neoplasms 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pleural Effusion, Malignant 2Pancreatic Neoplasms 2Lymphoma, Follicular 2Diverticulosis, Colonic 2Chronic Pain 2Breakthrough Pain 2post laminectomy syndrome 1Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thrombocythemia, Essential 1Terminal Cancer 1Sezary Syndrome 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1

Interventions

Fentanyl 1Dexmedetomidine 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Intrathecal Dexmedetomidine × Fentanyl × Clear all
NCT02861716 2018-04-10

Intrathecal Dexmedetomidine Versus Fentanyl With Bupivacaine in Children Undergoing Major Abdominal Cancer Surgery

South Egypt Cancer Institute

Phase 2 Unknown
60 enrolled
Other neoplasm

Intrathecal Dexmedetomidine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡